Clinical trial
Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers
NCT00003249 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003249 |
|---|---|
| Title | Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers |
| Official title | A Phase I Investigation of Carboxyamido-triazole (CAI) Modulated by Ketoconozole In Patients With Advanced Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | carboxyamidotriazole, chemotherapy, ketoconazole |
| Enrollment | 30 |
| Start date | May 1, 1998 |
| Primary completion | Dec 1, 2001 |
| First posted | Jun 3, 2004 |
| Last update posted | Feb 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: